Understanding the Overlap between MDS and PNH | Aplastic Anemia & MDS International Foundation Return to top.

Understanding the Overlap between MDS and PNH

Presenter(s): 
Topic(s): 
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Myelodysplastic Syndromes (MDS)
Presentation Date: 
Wednesday, December 16, 2020 (All day)

Dr. Navada discusses the overlap between MDS and PNH including the diagnosis process and best practices in treatment.  While this is a very rare overlap, it's important for MDS and PNH patients to be aware of the possibility. Participants will have the opportunity to ask questions during the session.

Shyamala Navada, MD, is Associate Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai (Icahn) and a faculty member of The Tisch Cancer Institute.  She has served as principal investigator on multiple investigator-initiated and industry-sponsored trials. Dr. Navada earned her M.D. from the University of Illinois and holds a Master of Science degree in Clinical Research from Icahn.

Dr. Navada has presented her research at national and international conferences, including the American Society of Hematology annual meeting, International Bone Marrow Failure Disease Scientific Symposium, International Symposium on Myelodysplastic Syndromes, and European Hematology Association Congress. 

Dr. Navada will be joining the AAMDSIF Patient Education Council in 2021 as an expert advisor on the Foundation's educational programming. 

Share with addtoany.com.